Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases - TREND Colombia
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2020
Price : $35 *
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms TREND
- Sponsors Bayer
- 03 Aug 2018 Status changed from active, no longer recruiting to completed.
- 10 Jul 2018 Planned End Date changed from 30 Jun 2018 to 30 Jul 2018.
- 10 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Jul 2018.